Información de la revista
Vol. 103. Núm. 4.
Páginas 288-293 (mayo 2012)
Visitas
8320
Vol. 103. Núm. 4.
Páginas 288-293 (mayo 2012)
Novelties in Dermatology
Acceso a texto completo
Tinea Capitis: Trends in Spain
Tendencias de la tinea capitis en España
Visitas
8320
J. del Boz-González
Servicio de Dermatología, Hospital Costa del Sol, Málaga, Spain
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Abstract

Considerable information is available on the changing incidence, etiology, clinical forms and management of tinea capitis in Spain. While the condition became epidemic during the 19th century, when it was predominantly caused by anthropophilic dermatophytes, the incidence fell with the advent of treatment with griseofulvin, after which zoophilic dermatophytes became the main etiologic agents. Although the true incidence of tinea capitis in Spain today is unknown, the condition continues to be a public health problem. Ongoing changes are evident in the greater diversity of pathogenic species identified and a renewed increase in anthropophilic dermatophytes, especially associated with immigration. Consequently, unless action is taken to correctly diagnose, treat, and prevent this infection, its prevalence may once again reach epidemic proportions in the near future.

Keywords:
Tinea capitis
Tineas
Dermatophytes
Resumen

Podemos encontrar abundante documentación publicada sobre la evolución de la tinea capitis (TC) en España, tanto en su incidencia como en su etiología, formas clínicas y manejo terapéutico. Si en el siglo XIX adoptó carácter de epidemia, con predominio de dermatofitos antropofílicos, tras la aparición de la griseofulvina su incidencia descendió y se produjo un viraje etiológico hacia un predominio de los dermatofitos zoofílicos. Aunque hoy en día su incidencia real es desconocida en nuestro medio, la TC sigue siendo un problema de salud pública y su evolución continúa produciéndose, pudiendo apreciarse una mayor diversidad de especies y fundamentalmente un nuevo aumento de los dermatofitos antropofílicos, especialmente en relación con la inmigración. Así, si no se incide en su correcto diagnóstico, tratamiento y profilaxis, su prevalencia puede volver a aumentar alcanzando proporciones de epidemia en un futuro próximo.

Palabras clave:
Tinea capitis
Tiña
Dermatofitos
Texto completo

Dermatophytoses (fungal infections of the skin, popularly called ringworm) vary in terms of clinical features and causative agents according to geographic area and even over time in the same geographic area,1–14 due to a large number of factors, mainly related to climate (humidity and temperature), socioeconomic circumstances (migration, hygiene, war, access to healthcare, etc), and treatment (nonspecific treatment, lack of effective treatments, new treatments, etc).1,3,9,10,12,15

These variations need to be studied and accounted for. Although dermatophytoses logically need to be treated according to the etiological diagnosis, based, in turn, on a physical examination and culture,16 empirical treatment is warranted in cases where lesions are inflammatory and symptomatic, and where there is a risk of contagion; in such cases the choice of treatment and recommendations for appropriate changes in hygiene and diet need to be guided by knowledge of the local epidemiology—by both the dermatologist and primary care physician.17 This would indicate the need for regular, localized epidemiology studies.9,18

In Spain, several studies have collected and analyzed epidemiological data1,4,7–10,12,19–31 from a regional6,32,33 and even national2,5,6,18,34,35 perspective. However, most of these studies collected data over relatively short periods of time, usually no more than one or a few years,9,10,17,18,20,22–25,27–30,33 although with some notable exceptions.1,6–8,19 Most were also retrospective studies of preselected populations with dermatologic disorders. Only 2 prospective studies have sought to establish the national incidence of ringworm of the scalp in children in Spain, reporting incidences of 0.23% and 0.64%.29,30 However, these studies are subject to selection bias: since they were conducted in urban areas with large immigrant populations, they were only partially representative of the Spanish population. Worthy of mention, nonetheless, are several large national studies regarding trends in dermatophytosis in Spain up to the late 20th century, based on analysis and review of studies published over many decades; noteworthy examples are the studies by Crespo et al.2 in 1999 and Pereiro et al.34 in 1996.

Ringworm of the scalp, or tinea capitis, is an infection of the scalp caused by dermatophytes of the genera Microsporum or Trichophyton.3,31,36 Tinea capitis, which occurs most frequently in children, remains the most common fungal infection among this population.3,17,36 In adults it is relatively rare but not unheard of, and mainly affects perimenopausal and elderly women. As we will see below, there have been clear trends in tinea capitis over the last few centuries in Spain, yet few national studies have been implemented that document this fungal infection.17,19,30,37 Tinea capitis was epidemic and a major public health problem in the 19th century in much of Europe, including Spain.3,19,38 Infectious agents were mainly anthropophilic, with Microsporum audouinii, Trichophyton schonleinii, Trichophyton violaceum, and Trichophyton tonsurans prevailing as causative agents in most of Western Europe (including Spain) and in the Mediterranean region.2,3,34 Especially prevalent was a particular type of inflammatory tinea capitis, called tinea favosa, or favus,3 usually caused by T schoenlinii.5 By the mid-20th century, the use of griseofulvin and improved hygiene significantly reduced the number of cases of tinea capitis3,7,38 by reducing the incidence of anthropophilic infections: the favus agent (T schonleinii) and certain microsporum-induced tineas (mainly those caused by M audouinii) virtually disappeared, and there was a significant decrease in the trichophytic tinea capitis agents (T tonsurans and T violaceum). The previously frequent outbreaks of tinea capitis in schools caused by the spread of anthropophilic dermatophytes were thus brought under control. Meanwhile, the anthropophilic agents came to be displaced (both in Spain and the rest of Europe) by zoophilic species (mainly Microsporum canis and Trichophyton mentagrophytes var. mentagrophytes).6,17,19Possible causes of the growing predominance of zoophilic dermatophytes are socioeconomic factors and the growing presence of pets in cities. In fact, the most commonly isolated dermatophyte in most cases of tinea capitis in Spain up to the early 21st century was M canis,6–9,17–20,22,27,32–34,39,40with cats and dogs as the usual source of infection (when identified), often infecting several members of the same family.14,17,19M canis is still considered to be the most commonly isolated dermatophyte for cases of tinea capitis worldwide,3 and is certainly so in Europe,36 most especially in the Mediterranean area (Italy, Croatia, Greece, etc). In most Spanish studies, T mentagrophytes (var. mentagrophytes) was the second most frequently isolated agent,1,6,7,9,17,19,32 including in our own series (where it was the most frequent cause of inflammatory tinea capitis)1; infection in this case was mainly attributed to contact with rabbits.17,26,28,39There now seems to be a new shift underway, back towards the predominance of the anthropophilic tineas in Europe, mainly in urban areas with high immigration (especially from Africa).17,19,36,41–43 Noteworthy is the increase in tinea capitis cases caused by T tonsurans in countries like the United Kingdom,12,42,44–46 Ireland,12 and Holland,47 and in cities like Paris,19 and also the fact that T violaceum was the most frequently isolated dermatophyte in tinea capitis studies performed in Turkey,48 Rotterdam,49 and Stockolm.50 Remarkable also is the growing incidence of infections caused by other anthropophilic dermatophytes, such as Trichophyton soudanense (in France, Germany, and Belgium36,41) and Microsporum audouinii (in France,51 the United Kingdom,36 and Belgium41).Developments in Spain are following a similar trend. Since the late 20th century, cases of tinea capitis caused by anthropophilic dermatophytes have been on the rise, typically in areas with large immigrant populations.1,8,30T tonsurans, for example, was isolated as a relatively frequent cause of tinea capitis in a study performed in Madrid,8 and was, in fact, the most frequently isolated dermatophyte in a prospective study.30 This agent was also isolated (although less frequently) as a cause of tinea capitis in studies conducted in Malaga,1 Cadiz,4 and Santiago de Compostela.17T violaceum, meanwhile, was also isolated as a very frequent cause of tinea capitis in recent studies conducted in Barcelona21 and Madrid,8 and was the anthropophilic dermatophyte most frequently isolated in another study in Malaga.1 This dermatophyte is closely associated with immigration from North Africa.52 Recent years have also witnessed a small increase in tinea capitis cases caused by anthropophilic dermatophytes considered rare in our setting, such as T soudanense (in Santiago de Compostela,17,34,53 Malaga,1 Cadiz,4 Zaragoza,19 and Madrid8) and M audouinii (in Madrid8 and Zaragoza19). The increase in anthropophilic infection should be a cause for concern,36 as it implies increased prevalence of tinea capitis in schools and associated family epidemics.

Clinical presentation of tinea capitis has also changed in line with changes in the pattern of infectious agents. Zoophilic dermatophytes cause microsporum-induced and commonly inflammatory tineas, which typically present with isolated or patchy hairless plaques, with ectothrix invasion in the form of spores outside the hair shaft; anthropophilic agents, on the other hand, typically cause noninflammatory trichophytic tineas, with a black dot pattern, and usually presenting as multiple irregular hairless plaques, with endothrix spore invasion within the hair shaft. Virtually nonexistent in Spain nowadays, but prevalent in the early 20th century was favus, a form of inflammatory tinea capitis characterized by the presence of highly contagious scabs formed of raised yellow cup-shaped crusts (scutula) that encircle the hair follicles. When the agent is anthropophilic, it is also important to screen household contacts for paucisymptomatic or asymptomatic carriers, given the high risk of contagion. This kind of contact, which makes it difficult to eradicate tinea capitis, may, in fact, explain the increase in infections with this etiology in urban areas.3,30,40,41,54Diagnostic methods have also advanced with the development of new procedures such as dermoscopy, which highlighted the recently described comma-hair marker.55 However, it is important to point out that the confirmatory diagnosis for suspected tinea capitis must always be based on a physical examination and culture. Physical examination to determine the kind of hair infestation will indicate the cause of the tinea capitis, and, hence, the specific treatment to follow; the culture will indicate whether the dermatophyte is zoophilic, anthropophilic, or geophilic, and will, in turn, indicate the prophylactic19 and therapeutic36 measures to be adopted.Treatment of tinea capitis has also varied over the years. Oral griseofulvin is still the treatment of choice for tinea capitis in children (and the only treatment approved for this population by the Food and Drug Administration),54,56-59 ever since its effectiveness was documented by Williams and Marten in 1958. The use of griseofulvin led, as we noted previously, to a significant reduction in epidemics; it also led to a decline in treatments hitherto used, including x-ray epilation (as proposed by Sabouraud at the end of the 19th century), thallium acetate, and mechanical epilation. Although the dose and duration of treatment varies depending on the patient,59,60 griseofulvin (in tablet form) is currently recommended at doses of 25-30mg/kg daily (up to 1g daily in adults). Note that, for Spain, where only the micronized formulation is available, the dose indicated in the summary of product characteristics (10–20mg/kg daily) is generally insufficient, as it corresponds to the dose for the ultramicronized formulation.56 Treatment duration, usually 6 to 12 weeks, mainly depends on the causative agent.59T tonsurans, for example, may require a longer treatment period, and there is a growing number of cases of dermatophyte resistance to griseofulvin.59 An alternative treatment, also recognized as effective, is terbinafine60-63 (250mg daily for adults), with the dose adjusted for children by weight (over 40kg: as for adults; 20-40kg: half the adult daily dose; under 20kg: quarter the adult daily dose). Although terbinafine may occasionally be ineffective for tineas caused by M canis and M audouinii,16,63 it has fewer drug interactions and may be useful in cases of suspected griseofulvin resistance.59 Similarly, the duration of treatment varies depending on the infectious agent; 2 to 4 weeks of treatment is recommended for Trichophyton infections and 8 to 12 weeks for Microsporum infections. To sum up, griseofulvin is recommended as the treatment of choice for suspected microsporum-induced tinea capitis.56,60 Terbinafine, on the other hand, is recommended for suspected Trichophyton infection, and for cases of griseofulvin resistance and polypharmacy, 56,59–61 as it is at least equally effective and safe, usually has a faster mechanism of action, requires a shorter treatment period, and has fewer drug interactions. Second-line drugs, much more costly than griseofulvin, are itraconazole,54,58,64 ketoconazole,65 and fluconazole.56,66 Topical antifungals, proven to be effective in reducing the risks of transmission and of reinfection and in shortening healing time, are useful as adjuvant treatment.56In the case of inflammatory tineas, the risk of scarring alopecia is high, so treatment needs to commence immediately. The drugs and doses prescribed above may be used, but some authors also advocate the concomitant use of antiinflammatory agents—usually prednisone at doses of 1mg/kg daily for 1-2 weeks—applied directly to the lesion in localized processes or taken systemically when involvement is diffuse.3 Oral antibiotics should only be prescribed if there is secondary bacterial infection.With regard to preventive measures, although recent studies state that there is no need for children (particularly older ones) to stay away from school while receiving treatment,54,57 this recommendation is controversial,41 as contact at school is probably the single most important independent factor in the rapid transmission of anthropophilic tineas.As mentioned previously, the possibility of contact with paucisymptomatic or asymptomatic carriers needs to be taken into account, especially with anthropophilic infection, given the high transmission risk.59 Cultures should be obtained, and the use of antifungal shampoos may be sufficient, even though their efficacy has not been established.3,9,30,41,67,68 To limit contagion within families due to suspected anthropophilic infection, the importance of not sharing personal hygiene items and of disinfecting the bath or shower after use by possibly infected individuals should be emphasized.41 Organisms responsible for tinea capitis have been cultivated from fomites such as combs, hats, pillows, and theater seats, where shed spores can survive for long periods of time, thereby helping to spread tinea capitis.3

Noteworthy is the relatively high number of tinea capitis cases referred to dermatology departments that have been treated incorrectly or inadequately, especially in recent years.1,69 This would indicate both a lack of proper treatment guidelines in primary care and a lack of communication with dermatologists; if not properly addressed, these oversights could result in new outbreaks.1,69

It is apparent that tinea capitis has been steadily changing in Spain since the 19th century. Since it is not a notifiable disease, its true incidence is unknown. Yet tinea capitis is considered today to be the most common fungal infection in childhood,3,29,36,39,51,67,68,70–72 and also a national public health issue, even if not as critical as in other regions of the world, where tinea capitis is endemic and where access to health care is limited.54,73–77

Due mainly to migratory flows, it seems likely that the epidemiology of tinea capitis in Spain will continue to change and to become increasingly diverse in terms of etiologic agents. If no efforts are invested to ensure proper diagnosis, treatment, and prevention, tinea capitis prevalence may grow to epidemic proportions in the near future. It is recommended to set up a good surveillance program (especially screening in schools) and ensure interdisciplinary cooperation between dermatologists, pediatricians, primary care physicians, and veterinarians.

Conflicts of Interest

The author declares no conflicts of interest.

Acknowledgments

Thanks to Dr. Vicente Crespo Erchiga, my mycology mentor, for critically reading this article.

References
[1]
J. Del Boz, V. Crespo, F. Rivas-Ruiz, M. de Troya.
A 30-year survey of paediatric tinea capitis in southern Spain.
J Eur Acad Dermatol Venereol, 25 (2011), pp. 170-174
[2]
V. Crespo, Á. Vera, A. Ojeda, A. Crespo, F. Sánchez-Fajardo.
Epidemiología de las tiñas en España.
Piel, 14 (1999), pp. 175-185
[3]
N. Rebollo, A.P. López-Barcenas, R. Arenas.
Tiña de la cabeza.
Actas Dermosifiliogr, 99 (2008), pp. 91-100
[4]
P. García-Martos, L. García-Agudo, E. Agudo-Pérez, F. Gil de Sola, M. Linares.
Dermatofitosis por hongos antropofílicos en Cádiz (1997-2008).
Actas Dermosifiliogr, 101 (2010), pp. 242-247
[5]
M. Pereiro Ferreirós, M. Loureiro Martínez.
Identificación de los dermatofitos más frecuentes en España.
Piel, 23 (2008), pp. 438-446
[6]
M. Pereiro Miguens, M. Pereiro, M. Pereiro Jr..
Review of dermatophytoses in Galicia from 1951 to 1987, and comparison with other areas of Spain.
Mycopathologia, 113 (1991), pp. 65-78
[7]
A. Del Palacio-Hernanz, F. González-Lastra, P. Moreno-Palancar.
Estudio de las dermatofitosis en Madrid durante una década (1978-1987).
Rev Iberoam Micol, 6 (1989), pp. 86-101
[8]
A. Del Palacio, M.S. Cuétara, A. Valle, A. González, I. Almondarain, M.J. Ramos Castillo, et al.
Cambios epidemiológicos observados en un decenio en las dermatofitosis del hospital universitario “12 de Octubre” de Madrid: nuevas especies emergentes.
Rev Iberoam Micol, 16 (1999), pp. 101-106
[9]
B. Fortuño, L. Torres, E. Simal, A. Seoane, J.A. Uriel, C. Santacruz.
Dermatofitos aislados en muestras clínicas. Estudio de 5 años en Zaragoza.
Enferm Infecc Microbiol Clin, 15 (1997), pp. 536-539
[10]
A. Martínez Roig, J.M. Torres Rodríguez.
Dermatophytosis in children and adolescents: epidemiological study in the city of Barcelona, Spain.
Mykosen, 29 (1986), pp. 311-315
[11]
M. Casal, M.J. Linares, J.C. Fernandez, F. Solis.
Dermatofitos y dermatofitosis en Cordoba (España).
Enferm Infecc Microbiol Clin, 9 (1991), pp. 491-494
[12]
A.M. Borman, C.K. Campbell, M. Fraser, E.M. Johnson.
Analysis of the dermatophyte species isolated in the British Isles between 1980 and 2005 and review of worldwide dermatophyte trends over the last three decades.
Med Mycol, 45 (2007), pp. 131-141
[13]
B. Havlickova, V.A. Czaika, M. Friedrich.
Epidemiological trends in skin mycoses worldwide.
[14]
L. Terragni, A. Lasagni, A. Oriani.
Dermatophytes and dermatophytoses in the Milan area between 1970 and 1989.
Mycoses, 36 (1993), pp. 313-317
[15]
A. Raza.
Ecology and epidemiology of dermatophyte infections.
J Am Acad Dermatol, 31 (1994), pp. S21-S24
[16]
A. Del Palacio, M. Garau, M.S. Cuétara.
Tratamiento actual de las dermatofitosis.
Rev Iberoam Micol, 19 (2002), pp. 68-71
[17]
B. Monteagudo, M. Pereiro Jr., C. Pereiro, J. Toribio.
Tinea capitis en el área sanitaria de Santiago de Compostela.
Actas Dermatosifiliogr, 94 (2003), pp. 598-602
[18]
A. Monzón de la Torre, M. Cuenca-Estrella, J.L. Rodriguez-Tudela.
Estudio epidemiológico sobre las dermatofitosis en España (abril-junio 2001).
Enferm Infecc Microbiol Clin, 21 (2003), pp. 477-483
[19]
C. Rubio-Calvo, J. Gil-Tomás, A. Rezusta-Lopez, R. Benito-Ruesca.
The aetiological agents of tinea capitis in Zaragoza (Spain).
Mycoses, 44 (2001), pp. 55-58
[20]
A. Herrera, J.A. Reposo, A. de la Iglesia, F. Ortiz.
Estudio epidemiológico de las dermatofitosis en las áreas sur y sudoeste de la provincia de Huelva (1989-1995).
Actas Dermosifiliogr, 88 (1997), pp. 179-183
[21]
T. Juncosa, P. Aguilera, A. Jaen, A. Vicente, A.C. Aguilar, V. Fumadó.
Trichophyton violaceum: un patógeno emergente.
Enferm Infecc Microbiol Clin, 26 (2008), pp. 502-504
[22]
E. Piqué, R. Fusté, R. Copado, J. Noguera, P. Ramis.
Estudio de las dermatofitosis en Lanzarote (1995-1999).
Rev Iberoam Micol, 19 (2002), pp. 165-168
[23]
R. Santana, D.M. Almazán, R.H. López-Orge, Z. González Lama.
Incidencia de las dermatomicosis en la población infantil.
An Esp Pediatr, 21 (1984), pp. 135-136
[24]
J.A. Velasco Benito, A. Martin-Pascual, A. Garcia Perez.
Epidemiologic study of dermatophytoses in Salamanca (Spain).
Sabouraudia, 17 (1979), pp. 113-123
[25]
J.I. López, M.I. Fernández, M. Egido.
Estudio de las micosis superficiales en la provincia de León.
Actas Dermosifiliogr, 84 (1993), pp. 525-528
[26]
J.L. Sánchez Carazo, J.J. Vilata Corell, J. de la Cuadra, A. Aliaga Boniche.
Contribución al estudio etiológico y epidemiológico de las tiñas en Valencia.
Actas Dermosifiliogr, 74 (1983), pp. 211-213
[27]
A. Padilla, A. Sampedro, P. Sampedro, V. Delgado.
Clinical and epidemiological survey of dermatophytoses in Jaen (Spain).
Rev Iberoam Micol, 19 (2002), pp. 36-39
[28]
J.M. Torres-Rodriguez, J. Balaguer-Meler, M. Ventin-Hernandez, N. Martin-Casabona.
Multicenter study of dermatophyte distribution in the metropolitan area of Barcelona (Catalonia, Spain).
Mycopathologia, 93 (1986), pp. 95-97
[29]
L. Triviño-Duran, J.M. Torres-Rodriguez, A. Martinez-Roig, C. Cortina, V. Belver, M. Perez-Gonzalez, et al.
Prevalence of tinea capitis and tinea pedis in Barcelona schoolchildren.
Pediatr Infect Dis J, 24 (2005), pp. 137-141
[30]
M.S. Cuétara, A. del Palacio, M. Pereiro, A.R. Noriega.
Prevalence of undetected tinea capitis in a prospective school survey in Madrid: emergence of new causative fungi.
Br J Dermatol, 138 (1998), pp. 658-660
[31]
V. Delgado Florencio, V. Crespo Erchiga.
Micosis cutáneas.
Medicine, 8 (2002), pp. 4805-4815
[32]
V. Delgado Florencio, J. Abad Romero-Balmas.
Cambios en la epidemiología de las tiñas. Aspectos particulares de Andalucía.
Rev Iberoam Micol, 16 (1999), pp. S3-S6
[33]
A. Mazón, S. Salvo, R. Vives, A. Valcayo, M.A. Sabalza.
Estudio etiológico y epidemiológico de las dermatofitosis en Navarra (España).
Rev Iberoam Micol, 14 (1997), pp. 65-68
[34]
M. Pereiro Miguens, E. Pereiro, M. Pereiro Jr., M. Pereiro, J. Toribio.
Incidencia de los dermatofitos en España desde 1926 a 1994.
Actas Dermosifiliogr, 87 (1996), pp. 77-84
[35]
G. Sais, A. Jucglá, J. Peyrí.
Prevalence of dermatophyte onychomycosis in Spain: a cross-sectional study.
Br J Dermatol, 132 (1995), pp. 758-761
[36]
G. Ginter-Hanselmayer, W. Weger, M. Ilkit, J. Smolle.
Epidemiology of tinea capitis in Europe: current state and changing patterns.
[37]
Y. Gilaberte, A. Rezusta, J. Gil, M.C. Sáenz-Santamaría, C. Coscojuela, M. Navarro, et al.
Tinea capitis in infants in their first year of life.
Br J Dermatol, 151 (2004), pp. 886-890
[38]
R.A. Schwartz, C.K. Janniger.
Tinea capitis.
Cutis, 55 (1995), pp. 29-33
[39]
Y. Gilaberte, M.C. Sáenz de Santamaría, C. Coscojuela, A. Rezusta López.
Tinea capitis en lactantes.
Piel, 18 (2003), pp. 21-29
[40]
M. Ginarte, M. Pereiro Jr., V. Fernández-Redondo, J. Toribio.
Case reports. Pityriasis amiantacea as manifestation of tinea capitis due to Microsporum canis.
Mycoses, 43 (2000), pp. 93-96
[41]
A. Kolivras, N. Lateur, J. De Maubeuge, C. Scheers, L. Wiame, M. Song.
Tinea capitis in Brussels: Epidemiology and new management strategy.
Dermatology, 206 (2003), pp. 384-387
[42]
J.G. Leeming, T.S. Elliot.
The emergence of Trichophyton tonsurans tinea capitis in Birmingham.
Br J Dermatol, 133 (1995), pp. 929-931
[43]
C. Viguié-Vallanet, M. Serre, L. Masliah, C. Tourte-Schaefer.
Épidemie de teignes á Trichophyton tonsurans dans una école maternelle de la region parisenne.
Ann Dermatol Venereol, 132 (2005), pp. 432-438
[44]
L.C. Fuller, F.C. Child, E.M. Higgins.
Tinea capitis in south-east London: an outbreak of Trichophyton tonsurans infection.
Br J Dermatol, 136 (1997), pp. 132-148
[45]
R.J. Hay, Y.M. Clayton, N. de Silva, G. Midgley, E. Rossor.
Tinea capitis in south-east-London- a new pattern of infection with public health implications.
Br J Dermatol, 135 (1996), pp. 955-958
[46]
C.M. Mills, C.M. Philpot.
Tinea capitis in South Wales-observations in change of causative fungi.
Clin Exp Dermatol, 19 (1994), pp. 473-475
[47]
M.J. Korstanje, C.C. Staats.
Fungal infections in the Netherlands. Prevailing fungi and pattern of infection.
Dermatology, 190 (1995), pp. 39-42
[48]
M. Altindis, E. Bilgili, N. Kiraz, A. Ceri.
Prevalence of tinea capitis in primary schools in Turkey.
Mycoses, 46 (2003), pp. 218-221
[49]
M.J. Korstanje, C.C.G. Staats.
Tinea capitis in northwestern Europe 1963-1993: etiologic agents and their changing prevalence.
Int J Dermatol, 33 (1994), pp. 548-549
[50]
J. Hallgren, B. Petrini, C.F. Wahlgren.
Increasing tinea capitis prevalence in Stockholm reflects immigration.
Med Mycol, 42 (2004), pp. 505-509
[51]
S. Reichert-Pénétrat, N. Contet-Audonneau, A. Barbaud, J.P. Schurra, B. Portier, J.L. Schmutz.
Epidemiology of dermatophytoses in children living in Northeast France: a 5-year study.
Pediatr Dermatol, 19 (2002), pp. 103-105
[52]
M.C. Rubio, A. Rezusta, J. Gil-Tomás, R. Benito-Ruesca.
Perspectiva micológica de los dermatofitos en el ser humano.
Rev Iberoam Micol, 16 (1999), pp. 16-22
[53]
M. Pereiro Jr., J. Toribio.
Tinea caused by Trichophyton soudanense in non-african subjects in Spain.
Acta Derm Venereol, 82 (2002), pp. 141-142
[54]
S. Ali, T.A.D. Graham, S.E.D. Fogie.
The assessment and management of tinea capitis in children.
Pediatr Emerg Care, 23 (2007), pp. 662-668
[55]
A.B. Crocker Sandoval, J.A. Soto Ortiz, J. Mayorga Rodríguez, A. García Vargas, D.G. Villanueva Quintero.
Hallazgos dermoscópicos en tinea capitis.
Rev Iberoam Micol, 27 (2010), pp. 151-153
[56]
T. Kakourou, U. Uksal.
Guidelines for the Management of Tinea Capitis in Children.
Pediatr Dermatol, 27 (2010), pp. 226-228
[57]
A.K. Gupta, E.A. Cooper, J.E. Ryder, K.A. Nicol, M. Chow, M.M. Chaudhry.
Optimal management of fungal infections of the skin, hair and nails.
Am J Clin Dermatol, 5 (2006), pp. 225-237
[58]
A. Sethi, R. Antaya.
Systemic antifungal therapy for cutaneous infections in children.
Pediatr Infect Dis J, 25 (2006), pp. 643-644
[59]
L.E. Millikan.
Current concepts in systemic and topical therapy for superficial mycoses.
Clin Dermatol, 28 (2010), pp. 212-216
[60]
H.L. Tey, A.S. Leong Tan, Y.C. Chan.
Meta-analysis of randomized, controlled trials comparing griseofulvin and terbinafine in the treatment of tinea capitis.
J Am Acad Dermatol, 64 (2011), pp. 663-670
[61]
A. Jaén-Larrieu, A. Vicente-Villa, P. Aguilera-Pérez, M.A. González-Enseñat, T. Juncosa-Morros, V. Fumadó-Pérez.
J Am Acad Dermatol, 21 (2009), pp. 1079-1080
[62]
G. Romero Aguilera, P. Cortina de la Calle, J.A. Garrido Martín, B. García Bracamonte, I. Barba Ferreras, M.D. Romero Aguilera.
Eficacia y seguridad de terbinafina (Lamisil®) oral en el tratamiento de las tiñas del cuero cabelludo por Microsporum canis.
Actas Dermosifiliogr, 89 (1998), pp. 564-565
[63]
A. Del Palacio Herranz, M.S. Cuétara, A. González Ruiz, A. Valle.
Respuesta a: Eficacia y seguridad de terbinafina (Lamisil®) oral en el tratamiento de las tiñas del cuero cabelludo por Microsporum canis.
Actas Dermosifiliogr, 89 (1998), pp. 565-566
[64]
A.K. Gupta, S. Nolting, Y. de Prost, J. Delescluse, H. Degreef, U. Theissen, et al.
The use of itraconazole to treat cutaneous fungal infections in children.
Dermatology, 199 (1999), pp. 248-252
[65]
A.A. Hebert.
Tinea capitis.
Arch Dermatol, 124 (1988), pp. 1554-1557
[66]
B.A. Solomon, R. Collins, R. Sharma, N. Silverberg, A.R. Jain, J. Sedgh.
Fluconazol for the treatment of tinea capitis in children.
J Am Acad Dermatol, 37 (1997), pp. 274-275
[67]
B. Escutia, I. Febrer, J. Pemán, V. Oliver, J.L. Sánchez-Carazo.
Tinea capitis por Microsporum audouinii.
Rev Iberoam Micol, 18 (2001), pp. 88-90
[68]
N.C. Fernandes, T. Akiti, M.G. Barreiros.
Dermatophytoses in children: study of 137 cases.
Rev Inst Med Trop Sao Paulo, 43 (2001), pp. 83-85
[69]
J. Del Boz, V. Crespo, F. Rivas-Ruiz, M. de Troya.
Tinea incognito in children: 54 cases.
[70]
T. Koussidou-Eremondi, D. Devliotou-Panagiotidou, O. Mourellou-Tsatsou, A. Minas.
Epidemiology of dermatomycoses in children living in Northern Greece 1996-2000.
[71]
B.E. Elewski.
Cutaneous mycoses in children.
Br J Dermatol, 134 (1996), pp. 7-11
[72]
J. Yu, R. Li, G. Bulmer.
Current topics of tinea capitis in China.
Jpn J Med Mycol, 46 (2005), pp. 61-66
[73]
J.I. Figueroa, T. Hawranek, A. Abraha, R.J. Hay.
Tinea capitis in south-western Ethiopia: a study of risk factors for infection and carriage.
Int J Dermatol, 36 (1997), pp. 661-666
[74]
A.R. Lari, L. Akhlaghi, M. Falahati, R. Alaghehbandan.
Characteristics of dermatophytoses among children in an area south of Tehran, Iran.
[75]
A.M. Nawaf, A. Joshi, A. Zaki, O. Nour-Eldin, M. Al-Sheltawy, I. El-Adawy, et al.
Tinea capitis among children and adolescents in the Farwaniya region of Kuwait.
J Dermatol, 30 (2003), pp. 904-909
[76]
R.S. Brilhante, R.A. Cordeiro, M.F. Rocha, A.J. Monteiro, T.E. Meireles, J.J. Sidrim.
Tinea capitis in a dermatology center in the city of Fortaleza, Brazil: the role of Trichophyton tonsurans.
Int J Dermatol, 43 (2004), pp. 575-579
[77]
V.J. Robertson, S. Wright.
A survey of tinea capitis in primary school in children in Harare, Zimbabwe.
J Trop Med Hyg, 93 (1990), pp. 419-422

Please cite this article as: del Boz-González J. Tendencias de la tinea capitis en España. Actas Dermosifiliogr.2012;103:288-293.

Copyright © 2011. Elsevier España, S.L. and AEDV
Descargar PDF
Idiomas
Actas Dermo-Sifiliográficas
Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?